您的位置: 首页 > 农业专利 > 详情页

Optimization of enzyme replacement therapy for treatment of homocystinuria
专利权人:
The Regents of the University of Colorado; a Body Corporate
发明人:
Kraus, Jan P.,Majtan, Tomas
申请号:
AU2018254410
公开号:
AU2018254410A1
申请日:
2018.04.17
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The present invention provides a method of PEGylating a human truncated cystathionine -synthase protein containing a mutation of a cysteine to a serine at amino acid position 15 (htCBS C15S). The htCBS C15S was PEGylated with one of 5 kDa, 10 kDa, or 20 kDa NHS ester PEG molecules. In-process monitoring of the PEGylation process was used in the method to reduce levels of unPEGylated htCBS C15S and htCBS C15S with insufficient PEGylation. Administration of the PEGylated htCBS C15S had efficacy throughout the course of treatment for homocystinuria.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充